Galectin Therapeutics Inc.

NasdaqCM:GALT Stock Report

Market Cap: US$216.7m

Galectin Therapeutics Balance Sheet Health

Financial Health criteria checks 0/6

Galectin Therapeutics has a total shareholder equity of $-60.2M and total debt of $71.7M, which brings its debt-to-equity ratio to -119.1%. Its total assets and total liabilities are $28.2M and $88.4M respectively.

Key information

-119.1%

Debt to equity ratio

US$71.74m

Debt

Interest coverage ration/a
CashUS$25.66m
Equity-US$60.24m
Total liabilitiesUS$88.44m
Total assetsUS$28.20m

Recent financial health updates

Recent updates

Galectin rises as FDA approves to begin human trial of combination immunotherapy in head and neck cancer

Oct 12

Galectin Therapeutics GAAP EPS of -$0.16

Aug 15

Galectin: Ability To Potentially Target Unmet Medical Need

Jul 11

Galectin: Pursuing A Subset In The NASH Space

Jul 01

Read This Before Buying Galectin Therapeutics, Inc. (NASDAQ:GALT) Shares

Feb 25
Read This Before Buying Galectin Therapeutics, Inc. (NASDAQ:GALT) Shares

Is Galectin Therapeutics (NASDAQ:GALT) In A Good Position To Deliver On Growth Plans?

Jan 21
Is Galectin Therapeutics (NASDAQ:GALT) In A Good Position To Deliver On Growth Plans?

How Much Of Galectin Therapeutics, Inc. (NASDAQ:GALT) Do Insiders Own?

Dec 09
How Much Of Galectin Therapeutics, Inc. (NASDAQ:GALT) Do Insiders Own?

Galectin Therapeutics reports Q3 results

Nov 09

Financial Position Analysis

Short Term Liabilities: GALT has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: GALT has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: GALT has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: GALT's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: GALT has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: GALT has less than a year of cash runway if free cash flow continues to reduce at historical rates of 21.8% each year


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.